We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$49.9K
AUM Growth
-$750K
Cap. Flow
-$753K
Cap. Flow %
-1,509.47%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$736K
2
SYBX
Synlogic
SYBX
+$17K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHWK
1
Whitehawk Therapeutics
WHWK
$208M
$49.9K 100%
26,666
– –
CSTL icon
2
Castle Biosciences
CSTL
$949M
– –
-36,747
Closed -$736K
SYBX
3
DELISTED
Synlogic
SYBX
– –
-13,727
Closed -$17K

Similar funds

FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return

ABG Innovation Capital Partners III's Q2 2025 Portfolio in Review

As of Q2 2025, ABG Innovation Capital Partners III held 3 positions worth $49.9K, down 94% from $800K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III withdrew a net $753K in Q2 2025, closing 2 positions. Its most notable exit was Castle Biosciences, an estimated $736K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III fully exited Castle Biosciences in Q2 2025, selling an estimated $736K.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $49.9K portfolio in Q2 2025.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 2 in Q2 2025.
  • ABG Innovation Capital Partners III's portfolio value fell 94% quarter-over-quarter to $49.9K.

Based on ABG Innovation Capital Partners III's 13F filing for Q2 2025, filed 14 Aug 2025.